Eli Lilly and Co at Cowen HealthCare Conference Transcript
I'd like to welcome Eli Lilly to the Cowen conference. Representing the company is Josh Smiley, who is the Chief Financial Officer. Let me note that next month marks the sixth year anniversary of the Cowen upgrade of Eli Lilly. And it was really an easy call because innovative, creative companies turn out to be good stocks in this industry, and Lilly has been a consistently good performer during that period. So Josh, thank you so much for spending this time with us.
I had the pleasure of having dinner last night with Josh with a small group of other people. And I think I follow the company pretty closely, and I listen to everything the company says, and I try to remember what the company says. And I guess I was most impressed with the conviction that you articulated for the outlook over the next 5 years. And again, I've heard it before, but I was just impressed with your confidence in your conviction, and I just wrote down a few things, which I'll just read off.
So revenue, top tier of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |